The adverse consequences of mephedrone use: A case series

Psychiatrist

Volumn 35, Issue 6, 2011, Pages 203-205

  Mackay, Kirsty ^a   Taylor, Mark ^a   Bajaj, Neeraj ^b  

^a NHS LOTHIAN   (United Kingdom)

^b NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4' METHYLMETHCATHINONE;

ADULT; ADVERSE OUTCOME; AGGRESSION; AGITATION; ARTICLE; CASE STUDY; CLINICAL ARTICLE; DISTRESS SYNDROME; DRUG INTOXICATION; DRUG USE; EMERGENCY WARD; FEMALE; HUMAN; MALE; MENTAL HEALTH SERVICE; MOOD DISORDER; RETROSPECTIVE STUDY; SELF REPORT; SUICIDE;

EID: 79957910368     PISSN: 17583209     EISSN: 17583217     Source Type: Journal    
DOI: 10.1192/pb.bp.110.032433     Document Type: Article

References (12)

1. Advisory Council on the Misuse of Drugs. Consideration of the Cathinones. ACMD, 2010 (http://www.homeoffice.gov.uk/publications/ drugs/acmd1/acmd- cathinodes-report-2010).
2. Cozzi NV, Sievert MK, Shulgin AT, Jacobill P, Ruoho AE. Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines. Eur J Pharmacology 1999; 381: 63-9. (Pubitemid 29488590)
3. Nagai F, Nonaka R, Kamimura KSH. The effects of non-medically used drugs on monoamine neurotransmission in rat brain. Eur J Pharmacology 2007; 559: 132-7. (Pubitemid 46295399)
4. Newcombe R. Mephedrone: The Use of Mephedrone (M-cat, Meow) in Middlesbrough. Lifeline Publications, 2009.
5. Dick D, Torrance C. MixMag drugs survey. MixMag 2010; 225: 44e53.
6. Wood DM, Greene SL, Dargan PI. Clinical pattern of toxicity associated with the novel synthetic cathinone mephedrone. Emerg Med J 2010; doi:10.1136/emj.2010.092288.
7. Warfa N, Klein A, Bhui K, Leavey G, Craig T, Stansfeld SA. Khat use and mental illness: a critical review. Soc Science Med 2007; 65: 309-18. (Pubitemid 46921301)
8. Curran C, Byrappa N, McBride A. Stimulant psychosis: systematic review. Br J Psychiatry 2004; 185: 196-204. (Pubitemid 39208220)
9. Wood DM, Davies S, Puchnarewicz M, Button J, Archer R, Ramsey J, et al. Recreational use of 4-methylmethcathinone (4-MMC) presenting with sympathomimetic toxicity and confirmed by toxicological screening. Clin Toxicology 2009; 47: 733.
10. Advisory Council on the Misuse of Drugs. Methylamphetamine Review. ACMD, 2005 (http://www.homeoffice.gov.uk/publications/drugs/ acmd1/ACMD-meth-report- November-2005).
11. EMCDDA, Europol. Europol-EMCDDA Joint Report on a New Psychoactive Substance: 4-Methylmethcathinone (Mephedrone). EMCDDA, Europol, 2010 (http://www.emcdda.europa.eu/attachements.cfm/att- 102496-EN-Europol-EMCDDA- Joint-Report-Mephedrone).
12. Nutt D. Mephedrone: the class D solution. Guardian 2010; 17 March (http://www.guardian.co.uk/commentisfree/2010/mar/17/ mephedrone-class-d- solution-criminalise?INTCMP=SRCH).